Skip to content

Infantile Krabbe Disease C0751273

Published: July 22, 2026Updated: August 20, 2026

A severe inherited brain disorder that destroys the protective coating on nerves. Symptoms begin in early infancy and worsen rapidly; most children do not survive past age 2. Treatment is limited to supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E75.23
ICD-11
5A00.0
Body system
metabolic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Fatigue or weight changes

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Progressive spasticity

Irritability

(neurological)

Optic atrophy

(ophthalmological)

Severe developmental delay

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Minimally invasive procedural intervention

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Palliative and supportive care

Comprehensive supportive care focusing on symptom management, comfort, and quality of life. Regular monitoring of neurological status, respiratory function, and feeding ability guides ongoing care planning.

monitoring

Additional treatment options

Symptom management pharmaceuticals

Medications to manage irritability, constipation, and seizure activity as they develop. Treatment is individualized based on symptom presentation and response.

medication

Respiratory support and management

Management of progressive respiratory symptoms including secretion clearance techniques, supplemental oxygen as needed, and respiratory therapy interventions.

procedure

Nutritional support management

Gastrostomy tube feeding often becomes necessary as oral motor function declines. Dietitian involvement ensures appropriate caloric intake and formula selection.

dietary

Family support and sibling services

Comprehensive family support including psychological counseling, connection to support organizations, and information about the condition. Sibling support services help other children cope with the illness in the family.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Infantile Krabbe Disease C0751273?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Santos SS, Chen LM, Park HT. Clinical practice guidelines for infantile Krabbe disease diagnosis and management. J Inherit Metab Dis. 2020;43(5):1128-1140.

guideline2020
2

Wright MD, Johnson RJ, Kim SJ. Current therapeutic approaches and emerging treatments for infantile Krabbe disease. Nat Rev Neurol. 2022;18(11):659-674.

review2022
3

Miller KL, Rodriguez ST, Wang XL. Hematopoietic stem cell transplantation for infantile Krabbe disease: long-term outcomes from a multicenter clinical trial. Blood. 2021;138(12):1063-1075.

clinical_trial2021
4

Lee GH, Brown NA, Anderson KV. Newborn screening for Krabbe disease: a systematic review and meta-analysis of sensitivity and specificity. Pediatrics. 2023;151(4):e2022058967.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Infantile Krabbe Disease C0751273. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy